Recursion Pharmaceuticals(us:RXRX)

    6.93

    +14.93%

    Updated on 2024-12-23

    Open:6.17
    Close:6.93
    High:6.99
    Low:6.10
    Pre Close:6.03
    Volume:16.29M
    Amount:106.44M
    Turnover:5.68%
    Shares:286.64M
    MarketCap:1.99B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-308119554594.45%430
    2024-03-3125520192280685.02%668569
    2023-12-3122819878179384.85%406982
    2023-09-3020614866377168.73%557257
    2023-06-3017912456738960.25%265868
    2023-03-3116612172125863.32%265544
    2022-12-3116212370032164.76%206249
    2022-09-3015410928372962.78%236240
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Ark Investment Management Llc2814291810.02%355535714.46%
    2024-06-30Baillie Gifford & Co265899369.46%252213210.48%
    2024-06-30Vanguard Group Inc215565467.67%554178234.60%
    2024-06-30Blackrock Inc.173101626.16%498912740.49%
    2024-06-30Ra Capital Management, L.P.153846155.48%15384615
    2024-06-30Mubadala Investment Co Pjsc129859274.62%0
    2024-06-30Kinnevik Ab (Publ)119056684.24%150000014.41%
    2024-06-30Sumitomo Mitsui Trust Holdings, Inc.99870303.55%-375773-3.63%
    2024-06-30Nikko Asset Management Americas, Inc.99344913.54%-428312-4.13%
    2024-06-30State Street Corp87495873.11%-1602769-15.48%

    About

    Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
    Address:41 South Rio Grande Street

    Market Movers